Gilead Sciences
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Sale
BISCHOFBERGER NORBERT W officer: EVP, R&D and CSO
 Common Stock 136,488 $59.16 $8,074,084
Option
YANG TAIYIN officer: SVP, Pharm Dev & Mfg
 Common Stock 99,046 $8.39 $830,600
Option
BISCHOFBERGER NORBERT W officer: EVP, R&D and CSO
 Common Stock 13,512 $7.4 $99,975
Option
BISCHOFBERGER NORBERT W officer: EVP, R&D and CSO
 Incentive Stock Option (right to buy) 13,512 $7.4 $99,975
Option
YANG TAIYIN officer: SVP, Pharm Dev & Mfg
 Incentive Stock Option (right to buy) 13,862 $9.7 $134,489
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 35,472 $10.55 $374,265
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Non-Qualified Stock Option (right to buy) 14,000 $9.34 $130,816
Sale
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 35,472 $59.42 $2,107,675
Sale
LEE WILLIAM A officer: SVP, Research
 Common Stock 10,000 $7.3 $72,970
Option
LEE WILLIAM A officer: SVP, Research
 Non-Qualified Stock Option (right to buy) 10,000 $7.3 $72,970
Option
LEE WILLIAM A officer: SVP, Research
 Common Stock 10,000 $7.3 $72,970
Sale
LEE WILLIAM A officer: SVP, Research
 Common Stock 40,000 $33.75 $1,349,920
Option
MILLIGAN JOHN F director, officer: President an..
 Common Stock 30,000 $11.76 $352,740
Sale
MILLIGAN JOHN F director, officer: President an..
 Common Stock 30,000 $60.56 $1,816,830
Option
MILLIGAN JOHN F director, officer: President an..
 Non-Qualified Stock Option (right to buy) 30,000 $11.76 $352,740
Option
YOUNG KEVIN officer: Chief Operating Officer
 Common Stock 25,000 $33.69 $842,125
Option
YOUNG KEVIN officer: Chief Operating Officer
 Non-Qualified Stock Option (right to buy) 25,000 $33.69 $842,125
Sale
YOUNG KEVIN officer: Chief Operating Officer
 Common Stock 25,000 $61.22 $1,530,400
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-qualified Stock Option (right to buy) 10,000 $13.6 $136,030
Option
YOUNG KEVIN officer: Chief Operating Officer
 Incentive Stock Option (right to buy) 2,828 $35.35 $99,970
Option
YOUNG KEVIN officer: Chief Operating Officer
 Non-quailified Stock Option (right to buy) 47,172 $35.35 $1,667,530
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 10,000 $60.25 $602,450
Sale
YOUNG KEVIN officer: Chief Operating Officer
 Common Stock 50,000 $60.4 $3,019,800
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 3,800 $8.21 $31,202
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Incentive Stock Option (right to buy) 3,800 $8.21 $31,202
Option
MILLIGAN JOHN F director, officer: President an..
 Common Stock 5,500 $7.19 $39,534
Option
MILLIGAN JOHN F director, officer: President an..
 Incentive Stock Option (right to buy) 5,500 $7.19 $39,534
Option
MARTIN JOHN C director
 Incentive Stock Option (right to buy) 44,640 $3.06 $136,732
Option
MARTIN JOHN C director
 Common Stock 44,640 $3.06 $136,732
Option
CARACCIOLO ANTHONY officer: SVP, Manufacturing
 Common Stock 130,890 $13.64 $1,785,340
Sale
YANG TAIYIN officer: SVP, Pharm Dev & Mfg
 Common Stock 20,000 $54.03 $1,080,540
Sale
BERG PAUL director
 Common Stock 6,000 $54.5 $327,000
Sale
CARACCIOLO ANTHONY officer: SVP, Manufacturing
 Common Stock 130,890 $54.1 $7,081,149
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 20,000 $9.34 $186,880
Sale
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 20,000 $54.02 $1,080,400
Option
CARACCIOLO ANTHONY officer: SVP, Manufacturing
 Incentive Stock Option (right to buy) 7,776 $7.4 $57,535
Option
LEE WILLIAM A officer: SVP, Research
 Common Stock 20,000 $7.41 $148,120
Option
LEE WILLIAM A officer: SVP, Research
 Non-Qualified Stock Option (right to buy) 20,000 $7.41 $148,120
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Non-Qualified Stock Option (right to buy) 20,000 $9.34 $186,880
Sale
LEE WILLIAM A officer: SVP, Research
 Common Stock 20,000 $54.06 $1,081,180
Option
MOORE NICHOLAS G director
 Common Stock 36,000 $29.07 $1,046,340
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right to buy) 5,010 $8.34 $41,763
Option
MARTIN JOHN C director
 Common Stock 120,000 $3.27 $391,920
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 18,010 $8.84 $159,226
Sale
MOORE NICHOLAS G director
 Common Stock 36,000 $54.09 $1,947,204
Option
MOORE NICHOLAS G director
 Non-qualified Stock Option (right to buy) 36,000 $29.07 $1,046,340
Sale
MARTIN JOHN C director
 Common Stock 120,000 $3.27 $391,920
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 18,010 $54.02 $972,972
Option
MARTIN JOHN C director
 Non-Qualified Stock Option (right to buy) 120,000 $3.27 $391,920
Sale
MILLIGAN JOHN F director, officer: President an..
 Common Stock 29,600 $54.42 $1,610,684

Showing 2750 to 2800 of 3053 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: